he global hyperbaric oxygen therapy devices market size is expected to be valued at US$ 3.21 Billion in 2022.
In 2022, it is anticipated that the market for devices used in hyperbaric oxygen therapy will be worth US$3.21 billion. The overall demand for hyperbaric oxygen therapy devices is anticipated to increase at a CAGR of 7.1% between 2022 and 2032, reaching approximately US$ 6.37 billion by 2032 due to the growing use of hyperbaric oxygen therapy in wound healing and the increasing number of athletes driving up demand for HBOT.
The use of the hyperbaric oxygen therapy (HBOT) technique improves leukocyte performance, particularly at the site of a wound, and reduces the toxicity of cyanide and carbon monoxide (CO). One of the major factors anticipated to propel the market during the forecast period is the technology’s increasing acceptance on a global scale.
The primary reason for the rise in demand for devices for hyperbaric oxygen therapy is the rising number of diabetic patients worldwide. As a result, the market will experience an upward trend over time. Additionally, the market is expected to grow as medical tourism rises. The government’s support and investment in the growing factors in the healthcare sector cannot be disregarded for the increase in demand. Additionally, this technology is now used to treat cancer patients as well as patients with brain injuries.
Get a Sample PDF Report @
https://www.futuremarketinsights.com/reports/sample/rep-gb-1099
One of the key factors anticipated to accelerate the growth of the hyperbaric oxygen therapy device market over the course of the analysis is the regulatory approval for a number of indications, including pulmonary embolism, severe anaemia, decompression sickness, burns, and brain abscesses, to name a few of the thirteen approved indications. One of the main factors anticipated to fuel market growth during the forecast period is the rising use of hyperbaric oxygen therapy devices for the treatment of lung disease and prevention of reperfusion injury.
In 2022, a 34.0% market share for hyperbaric oxygen therapy devices is anticipated in North America. A large portion of the market for hyperbaric oxygen therapy devices is expected to be in North America, thanks to factors like the region’s expanding population and growing interest in wound healing procedures.
Key Takeaways from the Market Study
Competitive Landscape
Players in the global Hyperbaric Oxygen Therapy Devices Market focus on expanding their global reach through various strategies, such as; partnerships, collaborations, and partnerships. The players are also making a significant investment in R&D to add innovations to their products which would help them in strengthening their position in the global market. Some of the recent developments among the key players are:
Inquire Before Buying Research Report@
https://www.futuremarketinsights.com/askus/rep-gb-1099
Key companies profiled:
Cardinal Health, Mölnlycke Health Care, Acelity L.P. Inc. (3M), Lohmann & Rauscher GmbH & Co. KG, Smith & Nephew, ConvaTec Inc., DeRoyal Industries, Inc., HARTMANN, Medela LLC, Haromed Bvba (Belgium), Carilex Medical GmbH. Genadyne Biotechnologies, Inc., Cork Medical, LLC, Alleva Medical Ltd. (Devon Medical Products, and Argentum Medical, LLC
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market.
Hyperbaric Oxygen Therapy Devices Market , Hyperbaric Oxygen Therapy Devices Market Share , Hyperbaric Oxygen Therapy Devices Market Size
Nov 02, 2022